<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><link rel="stylesheet" href="/css/isb.css" /><title>ProteomeXchange Dataset PXD021701</title>
</head><body bgcolor="#f4f6f8" marginwidth="0" marginheight="0">	<table width="100%" height="127" background="/images/topbackground.jpg" style="box-shadow: 0 6px 8px 0 rgba(0,0,0,0.3);">	<tr align="center"><td><a href="http://www.proteomexchange.org/" border="0"><img src="/images/proteomexchange.png"></a></td><td><a href="http://proteomecentral.proteomexchange.org/" border="0"><img src="/images/proteomecentral.png"></a></td></tr>	</table>		<!-- Main content area here --><!-- BEGIN main content -->

	 <link rel='stylesheet' id='style-css'  href='../javascript/css/patchwork.css' type='text/css' media='all' />
         <script type="text/javascript" src="/javascript/js/toggle.js"></script>
      
       <div id="main">
       <a class="linkback" href="http://proteomecentral.proteomexchange.org/cgi/GetDataset"> &lt;&lt;&lt; Full experiment listing </a>
       <div id="dataset-primary" class="site-content">
       <h1 class="dataset-title">PXD021701</h1>
    
	<div class="dataset-content">
	PXD021701 is an <b>original dataset</b> announced via ProteomeXchange.<BR><BR><div class='dataset-secthead'>Dataset Summary</div>
<table class='dataset-summary'><tr><td><b>Title</b></td><td>Large-scale and high-resolutionmass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting</td></tr><tr><td><b>Description</b></td><td class='breakwords'>Esophageal cancer (EC) is anaggressive cancer type without clinically relevant molecular subtypes defined, which hinders the development of effective strategies forEC treatment. Here, we reporteda large-scale, high-resolution massspectrometry-based proteomicand phosphoproteomics profiling of EC tumor and the corresponding adjacent non-tumor tissues, revealing a catalog of proteins, phosphositesas well as pathways that are dysregulated in ECs. The EC cohort was stratified into two molecular subtypes, S1 and S2, based on proteomic analysis, withthe S2 subtype characterized by the up-regulation of spliceosome and ribosomal proteins, and being more aggressive.Moreover, we identified a subtype signature composed of ELOA and SCAF4 and constructed a subtype diagnostic model, the accuracy of which was independently validated in a large cohort of EC patients (n=295). Potential drugs were predicted for treating patients in S2 subtype, and threecandidate drugs, GW8510, Menadione and Sulconazole,were validated to significantly inhibit the proliferation and migration of EC cell lines . On the basis of nude mice with xenograft tumors, we found that treatment with the three drugs markedly reduced the size of tumors. Finally, the three drugs were shown to reverse the expression patterns of most proteins that are dysregulated in S2 subtype in KYSE150 cells.Taken together, our proteomic analysis defined subtypesand subtype signature of EC, and providedmolecular basis for finding potential treatmentsfor EC.</td></tr><tr><td><b>HostingRepository</b></td><td>iProX</td></tr><tr><td><b>AnnounceDate</b></td><td>2021-07-05</td></tr>
                <tr><td><b>AnnouncementXML</b></td><td><a href='GetDataset?ID=PXD021701.0-2&outputMode=XML&test=no' target="_blank">Submission_2021-09-12_19:38:00.721.xml</a></td></tr>
                <tr><td><b>DigitalObjectIdentifier</b></td><td><a href="" target="_blank"></a></td></tr><tr><td><b>ReviewLevel</b></td><td>Peer-reviewed dataset</td></tr><tr><td><b>DatasetOrigin</b></td><td>Original dataset</td></tr><tr><td><b>RepositorySupport</b></td><td>Unsupported dataset by repository</td></tr><tr><td><b>PrimarySubmitter</b></td><td>Yaohui He</td></tr><tr><td><b>SpeciesList</b></td><td> scientific name: Trichuris sp. ex Homo sapiens JP-2011;  NCBI TaxID: 1035824; </td></tr><tr><td><b>ModificationList</b></td><td>phosphorylation without neutral loss</td></tr><tr><td><b>Instrument</b></td><td>Orbitrap Fusion ETD</td></tr></table>
<div class='dataset-secthead'>Dataset History</div>
<table class="dataset-summary">
<tr><th>Revision</th><th>Datetime</th><th>Status</th><th>ChangeLog Entry</th></tr>
<tr><td >0</td><td >2020-09-27 20:49:59</td><td >ID requested</td><td ></td></tr>
<tr><td ><a href="GetDataset?ID=PXD021701-1&test=no">1</a></td><td >2021-07-04 20:14:44</td><td >announced</td><td ></td></tr>
<tr><td class="dataset-currentrev"><a href="GetDataset?ID=PXD021701-2&test=no"><span class='current'>&#9205;</span> 2</a></td><td class="dataset-currentrev">2021-09-12 19:38:01</td><td class="dataset-currentrev">announced</td><td class="dataset-currentrev">2021-09-13: Update publication information.</td></tr>
</table>
<div class='dataset-secthead'>Publication List </div>
<table class='dataset-summary'>
<tr><td>Liu W, Xie L, He YH, Wu ZY, Liu LX, Bai XF, Deng DX, Xu XE, Liao LD, Lin W, Heng JH, Xu X, Peng L, Huang QF, Li CY, Zhang ZD, Wang W, Zhang GR, Gao X, Wang SH, Li CQ, Xu LY, Liu W, Li EM, Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting. Nat Commun, 12(1):4961(2021) [<a href="https://www.ncbi.nlm.nih.gov/pubmed?term=34400640" target="_blank">pubmed</a>]</td></tr></table>
<div class='dataset-secthead'>Keyword List </div>
<table class='dataset-summary'>
<tr><td>submitter keyword: Esophageal cancer，TMT，Proteomics</td></tr></table>
<div class='dataset-secthead'>Contact List </div>
<table class='dataset-summary'>
<tr><th colspan='2'>Liyan Xu</th></tr>
<tr><td>contact affiliation</td><td>Institute of Oncologic Pathology, Shantou University Medical College</td></tr><tr><td>contact email</td><td>lyxu@stu.edu.cn</td></tr><tr><td>lab head</td><td></td></tr><tr><th colspan='2'>Yaohui He</th></tr>
<tr><td>contact affiliation</td><td>School of Pharmaceutical Sciences,Xiamen University</td></tr><tr><td>contact email</td><td>yaohuihe@stu.xmu.edu.cn</td></tr><tr><td>dataset submitter</td><td></td></tr></table>
<div class='dataset-secthead'>Full Dataset Link List </div>
<table class='dataset-summary'>
<tr><td><a href=http://www.iprox.org/page/project.html?id=IPX0002501000 target="_blank">iProX dataset URI</a></td></tr></table>

      
	 </div><!-- #content -->
	 </div><!-- #primary .site-content -->
	 </div><!-- #main -->
      <!-- END main content -->	<!-- Begin Footer -->	<br clear="all">	<div class="footer">	<table width="100%"><tr>	<td style="vertical-align:top; text-align:left; padding: 10px;">If you have a question or comment about ProteomeXchange, please <a href="http://www.proteomexchange.org/contact">contact us</a>!<BR>	<a href="http://www.proteomexchange.org/subscribe/index.html"><img width="70" height="20" src="/images/subscribe_button-small.jpg"><font size="+1" color="#aa0000"> to receive all new ProteomeXchange dataset release announcements!</font></a>	</td>	<td style="text-align:right; padding: 10px;">	<a class="logolink" target="_blank" href="http://www.ebi.ac.uk/"><img src="/images/ebi_footer_logo.png"></a>&nbsp;&nbsp;&nbsp;&nbsp;	<a class="logolink" target="_blank" href="http://www.isbscience.org/"><img src="/images/isb.jpg"></a>&nbsp;&nbsp;&nbsp;&nbsp;	<a class="logolink" target="_blank" href="http://ec.europa.eu/research/fp7/index_en.cfm"><img src="/images/capacities.png"></a>	</td></tr></table>	</div>				</body></html>